Cargando…

Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †

Biphalin, one of the opioid agonists, is a dimeric analog of enkephalin with a high affinity for opioid receptors. Opioid receptors are widespread in the central nervous system and in peripheral neuronal and non-neuronal tissues. Hence, these receptors and their agonists, which play an important rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Redkiewicz, Patrycja, Dyniewicz, Jolanta, Misicka, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582929/
https://www.ncbi.nlm.nih.gov/pubmed/34768778
http://dx.doi.org/10.3390/ijms222111347
_version_ 1784597099042570240
author Redkiewicz, Patrycja
Dyniewicz, Jolanta
Misicka, Aleksandra
author_facet Redkiewicz, Patrycja
Dyniewicz, Jolanta
Misicka, Aleksandra
author_sort Redkiewicz, Patrycja
collection PubMed
description Biphalin, one of the opioid agonists, is a dimeric analog of enkephalin with a high affinity for opioid receptors. Opioid receptors are widespread in the central nervous system and in peripheral neuronal and non-neuronal tissues. Hence, these receptors and their agonists, which play an important role in pain blocking, may also be involved in the regulation of other physiological functions. Biphalin was designed and synthesized in 1982 by Lipkowski as an analgesic peptide. Extensive further research in various laboratories on the antinociceptive effects of biphalin has shown its excellent properties. It has been demonstrated that biphalin exhibits an analgesic effect in acute, neuropathic, and chronic animal pain models, and is 1000 times more potent than morphine when administered intrathecally. In the course of the broad conducted research devoted primarily to the antinociceptive effect of this compound, it has been found that biphalin may also potentially participate in the regulation of other opioid system-dependent functions. Nearly 40 years of research on the properties of biphalin have shown that it may play a beneficial role as an antiviral, antiproliferative, anti-inflammatory, and neuroprotective agent, and may also affect many physiological functions. This integral review analyzes the literature on the multidirectional biological effects of biphalin and its potential in the treatment of many opioid system-dependent pathophysiological diseases.
format Online
Article
Text
id pubmed-8582929
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85829292021-11-12 Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? † Redkiewicz, Patrycja Dyniewicz, Jolanta Misicka, Aleksandra Int J Mol Sci Review Biphalin, one of the opioid agonists, is a dimeric analog of enkephalin with a high affinity for opioid receptors. Opioid receptors are widespread in the central nervous system and in peripheral neuronal and non-neuronal tissues. Hence, these receptors and their agonists, which play an important role in pain blocking, may also be involved in the regulation of other physiological functions. Biphalin was designed and synthesized in 1982 by Lipkowski as an analgesic peptide. Extensive further research in various laboratories on the antinociceptive effects of biphalin has shown its excellent properties. It has been demonstrated that biphalin exhibits an analgesic effect in acute, neuropathic, and chronic animal pain models, and is 1000 times more potent than morphine when administered intrathecally. In the course of the broad conducted research devoted primarily to the antinociceptive effect of this compound, it has been found that biphalin may also potentially participate in the regulation of other opioid system-dependent functions. Nearly 40 years of research on the properties of biphalin have shown that it may play a beneficial role as an antiviral, antiproliferative, anti-inflammatory, and neuroprotective agent, and may also affect many physiological functions. This integral review analyzes the literature on the multidirectional biological effects of biphalin and its potential in the treatment of many opioid system-dependent pathophysiological diseases. MDPI 2021-10-21 /pmc/articles/PMC8582929/ /pubmed/34768778 http://dx.doi.org/10.3390/ijms222111347 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Redkiewicz, Patrycja
Dyniewicz, Jolanta
Misicka, Aleksandra
Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †
title Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †
title_full Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †
title_fullStr Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †
title_full_unstemmed Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †
title_short Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †
title_sort biphalin—a potent opioid agonist—as a panacea for opioid system-dependent pathophysiological diseases? †
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582929/
https://www.ncbi.nlm.nih.gov/pubmed/34768778
http://dx.doi.org/10.3390/ijms222111347
work_keys_str_mv AT redkiewiczpatrycja biphalinapotentopioidagonistasapanaceaforopioidsystemdependentpathophysiologicaldiseases
AT dyniewiczjolanta biphalinapotentopioidagonistasapanaceaforopioidsystemdependentpathophysiologicaldiseases
AT misickaaleksandra biphalinapotentopioidagonistasapanaceaforopioidsystemdependentpathophysiologicaldiseases